Quinupristin + Dalfopristin
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium (VREF) bacteremia.
- Complicated skin and skin structure infections caused by Staphylococcus aureus (MSSA) or Streptococcus pyogenes.
NON-FDA APPROVED USES
- Endocarditis (generally not recommended due to poorer clearance of bacteremia)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium (VREF) bacteremia.
- Complicated skin and skin structure infections caused by Staphylococcus aureus (MSSA) or Streptococcus pyogenes.
NON-FDA APPROVED USES
- Endocarditis (generally not recommended due to poorer clearance of bacteremia)
There's more to see -- the rest of this topic is available only to subscribers.